Retraction Note to: Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin. Breast Cancer Res Treat (2014) 147:203-10

Breast Cancer Res Treat. 2015 Jun;151(2):479. doi: 10.1007/s10549-015-3399-y.
No abstract available

Publication types

  • Retraction Notice